0001179110-17-013545.txt : 20171030
0001179110-17-013545.hdr.sgml : 20171030
20171030193013
ACCESSION NUMBER: 0001179110-17-013545
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171027
FILED AS OF DATE: 20171030
DATE AS OF CHANGE: 20171030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Misfeldt Dayton
CENTRAL INDEX KEY: 0001461466
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51531
FILM NUMBER: 171163723
MAIL ADDRESS:
STREET 1: C/O BAY CITY CAPITAL LLC
STREET 2: 750 BATTERY STREET, SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001061027
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943295878
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-266-3500
MAIL ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19980709
4
1
edgar.xml
FORM 4 -
X0306
4
2017-10-27
0
0001061027
SUNESIS PHARMACEUTICALS INC
SNSS
0001461466
Misfeldt Dayton
C/O BAY CITY CAPITAL LLC
750 BATTERY STREET, SUITE 400
SAN FRANCISCO
CA
94111
1
0
0
0
Common Stock
2017-10-27
4
P
0
392520
2.0
A
1598260
I
See footnotes.
Common Stock
2017-10-27
4
P
0
7480
2.0
A
30456
I
See footnotes.
Common Stock
252
I
See footnotes.
Common Stock Warrants (right to buy)
3.00
2017-10-27
4
P
0
196260
A
2017-10-27
2018-10-27
Common Stock
196260
196260
I
See footnotes.
Common Stock Warrants (right to buy)
3.0
2017-10-27
4
P
0
3740
A
2017-10-27
2018-10-27
Common Stock
3740
3740
I
See footnotes.
The reporting person is a Managing Director of Bay City Capital LLC, a Delaware limited liability company ("BCC"). BCC is the manager of Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"). Management V is the general partner of Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V") and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V") and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC, the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held. Mr. Misfeldt, BCC and Management V disclaim beneficial ownership with respect to the securities reported in this Form 4, except to the extent of their pecuniary interest therein.
The securities are held by Fund V.
The securities are held by Co-Investment V.
The securities are held by BCC.
The reported securities are included within the 392,520 shares of common stock and accompanying warrants purchased by the reporting person. The per share price of $2.00 includes one share of common stock and the accompanying warrant to purchase 0.5 share of common stock.
The reported securities are included within the 7,480 shares of common stock purchased by the reporting person. The per share price of $2.00 includes one share of common stock and the accompanying warrant to purchase 0.5 share of common stock.
/s/ Dayton Misfeldt
2017-10-30